Search Results For "kenshi"
The results for the first half of 2018 show that there is a greater tendency for hits to be born from their strength in the digital metrics such as downloads, streaming and video views compared to last year in the Japanese market. CDs continue to be an important medium to satisfy ardent fans who prefer to own music in this format, while the use of social media to reach out to a wider audience to spread the music has also become a crucial factor for a song to become a hit.
Search Results for "kenshi"
Bio: The swordsman Takahashi Kenshi spent his early adulthood searching the world for worthy opponents. When the sorcerer Shang Tsung duped him into retrieving the enchanted sword Sento from the Well of Souls, the result left Kenshi sightless. Humbled but with a new sense of purpose, Kenshi vowed to rid the realms of despicable creatures like Shang. He served Earthrealm admirably in its conflict with Netherrealm. In his post-war travels he met and fell in love with a young Thai-American woman.
Bio (in-game): For years the swordsman Kenshi traveled the world in search of worthy opponents. When a mysterious elderly man named Song offered to show him the location of Sento, an ancient sword worthy of his abilities, Kenshi succumbed to pride. He followed Song to a tomb wherein lay the Well of Souls. When Kenshi retrieved the sword, spirits of ancient warriors spewed forth, blinding him. Song then revealed himself to be Shang Tsung. He consumed the sol, leaving Kenshi in the dark labyrinth to die. But Sento called to Kenshi. It led him out of the tomb and revealed his lost heritage as a descendant of the warriors who had been buried there. Kenshi vowed to slay Shang Tsung and free the souls of his ancestors.
Bio (in-game): Sensing the cries of his captured ancestors, Kenshi made a vow to slay Shang Tsung in order to free them from his grasp. When he learned of Shang Tsung's escape to Outworld, Kenshi agreed to help the Special Forces search for the missing agent Cyrax as a means of gaining access to that realm, which allowed him to act as both rescue party and spy. Shortly after discovering the sorcerer's whereabouts, the Agency was destroyed and with it his only means for return to Earth. Kenshi now finds himself facing the Deadly Alliance on his own.
Objective To compare clinical outcomes among patients receiving drug-eluting stents, bare metal stents, or coronary artery bypass grafting surgery (CABG) to treat coronary artery disease. Data sources Randomised controlled trials were systematically selected from electronic database for head-to-head comparisons. The results from these head-to-head comparisons were used for an adjusted indirect comparison. Methods Published randomised controlled trials were reviewed for outcome data in patients treated for coronary artery disease with drug-eluting stents, bare metal stents, or CABG. Head-to-head comparisons were conducted for drug-eluting stents versus bare metal stents and for CABG versus bare metal stents. Adjusted indirect comparison was used to compare drug-eluting stents and CABG. Mid-term clinical outcomes (range: 6-12 months) were investigated and included rates of mortality, myocardial infarction, thrombosis, target lesion revascularisation, target vessel revascularisation, restenosis and major adverse cardiac events. Results Systematic literature search identified 23 randomised controlled trials (15 for drug-eluting stents vs. bare metal stents, 8 for CABG vs. bare metal stents). Head-to-head comparisons for both single and multiple vessel disease demonstrated that compared with bare metal stents, drug-eluting stents had better outcomes for target lesion revascularisation, target vessel revascularisation, restenosis and major adverse cardiac events. Except target lesion revascularisation, data were similarly favourable for CABG when compared with bare metal stents. Adjusted indirect comparison between drug-eluting stents and CABG in single vessel disease failed to detect significant differences in any of the measured outcomes. Multiple vessel disease data analysis demonstrated that target vessel revascularisation (odds ratio 3.41 [95% CI 2.29-5.08]) and major adverse cardiac events (1.89 [1.28-2.79]) were superior to drug-eluting stents in patients undergoing CABG. Conclusions Drug-eluting stents and CABG were superior to bare metal stents in terms of target lesion revascularisation (drug-eluting stents only), target vessel revascularisation, restenosis and major adverse cardiac events. There was no difference in clinical outcomes when comparing CABG and drug-eluting stents in patients with single vessel disease, and CABG may be superior to drug-eluting stents for target vessel revascularisation and major adverse cardiac events in patients with multiple vessel disease. However, results may vary between subpopulations with different clinical or socioeconomic differences.